Microalgae into medicine: Biotech startup targets shrimp, salmon diseases

Tim Sprinkle

MicroSynbiotiX developing versatile oral vaccines intended for wide range of species Antonio Lamb, chief operating officer and co-founder at MicroSynbiotiX, poses with Simon Jegan Porphy, CEO and co-founder. The company is employing the power of transgenic microalgae to make it cheaper and easier for aquaculture producers to administer vaccines to fish. To break aquaculture’s costly…

Global Aquaculture Advocate articles are free to read.
Please log in or create your own free profile.

  • Tim Sprinkle

    Tim Sprinkle

    Tim Sprinkle is a writer based in Denver, Colo. His work has appeared in Wired, Outside and many other publications, and he is the author of the 2015 book, “Screw the Valley: A Coast-to-Coast Tour of America’s New Tech Startup Culture.”